We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+3.95%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
AUM
$180M
AUM Growth
+$47.3M
Cap. Flow
-$45.9M
Cap. Flow %
-25.57%
Top 10 Hldgs %
70.76%
Holding
129
New
37
Increased
17
Reduced
26
Closed
31

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$4.98M
2
AMGN icon
Amgen
AMGN
+$2.4M
3
BKNG icon
Booking.com
BKNG
+$2.14M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$2.13M
5
NNDM
Nano Dimension
NNDM
+$1.39M

Sector Composition

Rank Sector Weight
1 Healthcare 8.5%
2 Technology 5.71%
3 Consumer Discretionary 1.17%
4 Industrials 1.07%
5 Energy 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPRT
101
Westport Fuel Systems
WPRT
$33.8M
-20,000
Closed -$265K
XLE icon
102
State Street Energy Select Sector SPDR ETF
XLE
$39.3B
-1,410
Closed -$39K
XLC icon
103
State Street Communication Services Select Sector SPDR ETF
XLC
$22.1B
-5,388
Closed -$221K
XLRE icon
104
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.57B
-2,948
Closed -$91K
WTT
105
DELISTED
Wireless Telecom Group, Inc.
WTT
-18,099
Closed -$32K
IEC
106
DELISTED
IEC Electronics Corp.
IEC
-8,800
Closed -$48K
APHA
107
DELISTED
Aphria Inc. Common Shares
APHA
-2,309
Closed -$12K
NEOS
108
DELISTED
Neos Therapeutics, Inc
NEOS
-150,586
Closed -$248K
IMMU
109
CALL
DELISTED
Immunomedics Inc
IMMU
-128,100
Closed -$999K
IMMU
110
PUT
DELISTED
Immunomedics Inc
IMMU
-157,100
Closed -$88K
WFT
111
PUT
DELISTED
Weatherford International plc
WFT
-39,500
Closed -$38K
KEM
112
DELISTED
KEMET Corporation
KEM
-42,000
Closed -$735K
BDSI
113
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-204,256
Closed -$754K
VVUS
114
DELISTED
Vivus Inc
VVUS
-50,292
Closed -$111K
ATTU
115
DELISTED
Attunity Ltd
ATTU
-28,504
Closed -$560K

Similar funds

Worth Venture Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Worth Venture Partners held 129 positions worth $180M, up 36% from $132M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Worth Venture Partners withdrew a net $45.9M in Q1 2019, closing 31 positions and reducing 26 holdings. Its most notable exit was State Street SPDR Portfolio Short Term Corporate Bond ETF, an estimated $2.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 8.5% of assets, up from 3.7% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Worth Venture Partners opened a new position in Biogen worth $3.73M.

  • Worth Venture Partners's largest Q1 2019 buy was Biogen: 15,800 shares worth $3.73M.
  • Worth Venture Partners added most to BioMarin Pharmaceuticals in Q1 2019, an estimated $2.13M increase.
  • Worth Venture Partners's biggest Q1 2019 reduction was Qualcomm, cutting an estimated $2.81M.
  • Worth Venture Partners fully exited State Street SPDR Portfolio Short Term Corporate Bond ETF in Q1 2019, selling an estimated $2.32M.
  • Worth Venture Partners's ten largest holdings make up 71% of its $180M portfolio in Q1 2019.
  • Worth Venture Partners opened 37 new positions and closed 31 in Q1 2019.
  • Worth Venture Partners's portfolio value rose 36% quarter-over-quarter to $180M.

Based on Worth Venture Partners's 13F filing for Q1 2019, filed 15 May 2019.